(Q57591266)

1

0 references

Cécile Couchoud

3

0 references

Thierry Hannedouche

4

0 references

Emmanuel Villar

5

0 references

Luc Frimat

6

0 references

Anne Fagot-Campagna

7

0 references

Christian Jacquelinet

https://scigraph.springernature.com/pub.10.1007/s00125-014-3160-9

8

0 references

publication date

6 February 2014

0 references

published in

Diabetologia

0 references

volume

57

0 references

issue

4

0 references

page(s)

718-728

0 references

exact match

0 references

cites work

An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

End-stage renal disease in the United States: an update from the United States Renal Data System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Changing trends in end-stage renal disease due to diabetes in the United kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Stabilized incidence of diabetic patients referred for renal replacement therapy in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

[The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys (2001 and 2007).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Renal replacement therapy in Europe: the results of a collaborative effort by the ERA-EDTA registry and six national or regional registries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Analysing the difference due to risk and demographic factors for incidence or mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Access to care and the incidence of end-stage renal disease due to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Renal replacement therapy in patients with diabetes and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

The timing of dialysis initiation affects the incidence of renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Risk factors for progressive chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Medical and non-medical determinants of access to renal transplant waiting list in a French community-based network of care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Age and comorbidity may explain the paradoxical association of an early dialysis start with poor survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Evaluation and determinants of underprescription of erythropoiesis stimulating agents in pre-dialysis patients with anaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3160-9

Anemia with impaired erythropoietin response in diabetic patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24496924

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expert consensus on management of diabetic patients with impairment of renal function

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24496924

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Managing anaemia and diabetes: a future challenge for nephrologists

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24496924